{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:36:54Z","timestamp":1786995414137,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:00:00Z","timestamp":1608854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013996","name":"Global Health Innovative Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.parint.2020.102277","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T10:24:45Z","timestamp":1608891885000},"page":"102277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda"],"prefix":"10.1016","volume":"81","author":[{"given":"Naoyuki","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichiro","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Sakurai-Yatsushiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Balikagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osbert T.","family":"Katuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakurako","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouki","family":"Yatsushiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sekihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Opio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Obwoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Auma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis A.","family":"Anywar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirianne M.Q.","family":"Palacpac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel I.","family":"Odongo-Aginya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ogwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.parint.2020.102277_bb0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.parint.2020.102277_bb0010","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/mdh.2013.69","article-title":"Malaria and quinine resistance: a medical and scientific issue between Brazil and Germany (1907\u201319)","volume":"58","author":"da Silva","year":"2014","journal-title":"Med. Hist."},{"key":"10.1016\/j.parint.2020.102277_bb0020","author":"World Health Organization"},{"issue":"4","key":"10.1016\/j.parint.2020.102277_bb0025","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.parint.2020.102277_bb0030","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.00366-15","article-title":"Ex vivo drug susceptibility testing and molecular profiling of clinical Plasmodium falciparum isolates from cambodia from 2008 to 2013 suggest emerging piperaquine resistance","volume":"59","author":"Chaorattanakawee","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.parint.2020.102277_bb0035","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.parint.2020.102277_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12936-020-03157-0","article-title":"Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda","volume":"19","author":"Balikagala","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.parint.2020.102277_bb0050","author":"The Republic of Uganda Ministry of Health"},{"key":"10.1016\/j.parint.2020.102277_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2293-6","article-title":"Insecticide resistance status of the malaria mosquitoes: Anopheles gambiae and Anopheles funestus in eastern and northern Uganda","author":"Okia","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.parint.2020.102277_bb0060","article-title":"Influence of climatic factors on malaria epidemic in Gulu District, northern Uganda: a 10-year retrospective study","volume":"2018","author":"Simple","year":"2018","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.parint.2020.102277_bb0065","author":"Uganda Bureau of Statistics (UBOS) and ICF International"},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12936-018-2585-x","article-title":"Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea","volume":"17","author":"Sekihara","year":"2018","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.parint.2020.102277_bb0075","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1128\/AAC.46.6.1658-1664.2002","article-title":"Histidine-rich protein II: a novel approach to malaria drug sensitivity testing","volume":"46","author":"Noedl","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.parint.2020.102277_bb0080","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/AAC.02350-12","article-title":"High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool, Antimicrob","volume":"57","author":"Woodrow","year":"2013","journal-title":"Agents Chemother."},{"key":"10.1016\/j.parint.2020.102277_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12936-016-1173-1","article-title":"Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms","volume":"15","author":"Wirjanata","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.parint.2020.102277_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12936-015-0769-1","article-title":"Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso","volume":"14","author":"Tahita","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.parint.2020.102277_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12936-015-0586-6","article-title":"Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine","volume":"14","author":"Pascual","year":"2015","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.parint.2020.102277_bb0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","article-title":"In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria","volume":"120","author":"Folarin","year":"2011","journal-title":"Acta Trop."},{"issue":"4","key":"10.1016\/j.parint.2020.102277_bb0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.parint.2020.102277_bb0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.parint.2020.102277_bb0115","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","article-title":"pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum","volume":"57","author":"Sidhu","year":"2005","journal-title":"Mol. Microbiol."},{"issue":"8","key":"10.1016\/j.parint.2020.102277_bb0120","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/AAC.47.8.2418-2423.2003","article-title":"Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1","volume":"47","author":"Pickard","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9432","key":"10.1016\/j.parint.2020.102277_bb0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parint.2020.102277_bb0130","author":"R Core Team"},{"issue":"10","key":"10.1016\/j.parint.2020.102277_bb0135","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/AAC.00367-06","volume":"50","author":"Kaddouri","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmpb.2010.08.003","article-title":"Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression","volume":"104","author":"Le Nagard","year":"2011","journal-title":"Comput. Methods Prog. Biomed."},{"issue":"5 Suppl","key":"10.1016\/j.parint.2020.102277_bb0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4269\/ajtmh.2012.11-0791","article-title":"Private sector drug shops in integrated community case management of malaria, pneumonia, and diarrhea in children in Uganda","volume":"87","author":"Awor","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.parint.2020.102277_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01516-17","article-title":"Changing antimalarial drug sensitivities in Uganda","volume":"61","author":"Rasmussen","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.parint.2020.102277_bb0155","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/AAC.01412-09","article-title":"In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda","volume":"54","author":"Nsobya","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2020.102277_bb0160","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1475-2875-12-450","article-title":"A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs","volume":"12","author":"Quashie","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.parint.2020.102277_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12936-015-0589-3","article-title":"Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013\u20132014 malaria season","volume":"14","author":"Fall","year":"2015","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12936-019-3089-z","article-title":"In vivo\/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso","volume":"19","author":"Lingani","year":"2020","journal-title":"Malar. J."},{"issue":"8","key":"10.1016\/j.parint.2020.102277_bb0175","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3201\/eid2608.191547","article-title":"Increased sensitivity of Plasmodium falciparum to artesunate\/amodiaquine despite 14 years as first-line malaria treatment, Zanzibar","volume":"26","author":"Msellem","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.parint.2020.102277_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064299","article-title":"The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008\u20132011","volume":"8","author":"Eyase","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.parint.2020.102277_bb0185","first-page":"111","article-title":"In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (C\u00f4te d\u2019Ivoire)","volume":"10","author":"Yavo","year":"2010","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.parint.2020.102277_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2875-13-63","article-title":"In vitro studies on the sensitivity pattern of Plasmodium falciparum to anti-malarial drugs and local herbal extracts","volume":"13","author":"Olasehinde","year":"2014","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.parint.2020.102277_bb0195","article-title":"Mefloquine for preventing malaria in pregnant women","volume":"3","author":"Gonz\u00e1lez","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parint.2020.102277_bb0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1475-2875-12-441","article-title":"Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal","volume":"12","author":"Van Tyne","year":"2013","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.parint.2020.102277_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01393-18","article-title":"Modeling prevention of malaria and selection of drug resistance with different dosing schedules of dihydroartemisinin-piperaquine preventive therapy during pregnancy in Uganda","volume":"63","author":"Wallender","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.parint.2020.102277_bb0210","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/infdis\/jiy637","article-title":"Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children","volume":"219","author":"Yeka","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.parint.2020.102277_bb0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.parint.2020.102277_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molbiopara.2011.01.012","article-title":"Update on genetic markers of quinine resistance in Plasmodium falciparum","volume":"177","author":"Okombo","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"issue":"9753","key":"10.1016\/j.parint.2020.102277_bb0225","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"Dondorp","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0230","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1186\/s12879-017-2924-5","article-title":"Intravenous artesunate plus Artemisnin based combination therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial","volume":"17","author":"Byakika-Kibwika","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.parint.2020.102277_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of Pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso","volume":"11","author":"Sondo","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.parint.2020.102277_bb0240","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","article-title":"Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial","volume":"213","author":"Yeka","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.parint.2020.102277_bb0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11908-017-0579-4","article-title":"Triple combination therapy and drug cycling-tangential strategies for countering artemisinin resistance","volume":"19","author":"Dipanjan","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"4","key":"10.1016\/j.parint.2020.102277_bb0250","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4269\/ajtmh.2003.68.413","article-title":"Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi","volume":"68","author":"Mita","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.parint.2020.102277_bb0255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1086\/655659","article-title":"Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites","volume":"202","author":"Laufer","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.parint.2020.102277_bb0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jiph.2016.02.004","article-title":"Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal","volume":"10","author":"Asare","year":"2017","journal-title":"J. Infect. Public Health"},{"issue":"6","key":"10.1016\/j.parint.2020.102277_bb0270","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"Sisowath","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"10233","key":"10.1016\/j.parint.2020.102277_bb0275","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576920302270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576920302270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:34:32Z","timestamp":1761302072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576920302270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":54,"alternative-id":["S1383576920302270"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2020.102277","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2020.102277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102277"}}